Natera (NTRA) Capital Expenditures Growth (1y) (2015 - 2026)
Powered by 
Analysis
Natera (NTRA) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 144.93% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 27.78% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 68.93% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 108.16% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 136.94% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 1,492.71% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 48.74% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 40.88% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 80.76% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 30.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 144.93% |
| Mar 31, 2026 | 1.48% |
| Dec 31, 2025 | 99.09% |
| Sep 30, 2025 | 37.35% |
| Jun 30, 2025 | 121.76% |
| Mar 31, 2025 | 7.38% |
| Dec 31, 2024 | 80.24% |
| Sep 30, 2024 | 82.11% |
| Jun 30, 2024 | 32.55% |
| Mar 31, 2024 | 78.51% |
| Dec 31, 2023 | -15.01% |
| Sep 30, 2023 | -26.64% |
| Jun 30, 2023 | 13.30% |
| Mar 31, 2023 | -28.36% |
| Dec 31, 2022 | 31.37% |
| Sep 30, 2022 | -7.06% |
| Jun 30, 2022 | -9.91% |
| Mar 31, 2022 | 54.82% |
| Dec 31, 2021 | 19.55% |
| Sep 30, 2021 | 576.07% |